US20030068375A1 - Pharmaceutical formulation containing gelling agent - Google Patents

Pharmaceutical formulation containing gelling agent Download PDF

Info

Publication number
US20030068375A1
US20030068375A1 US10/214,412 US21441202A US2003068375A1 US 20030068375 A1 US20030068375 A1 US 20030068375A1 US 21441202 A US21441202 A US 21441202A US 2003068375 A1 US2003068375 A1 US 2003068375A1
Authority
US
United States
Prior art keywords
dosage form
controlled release
drug
gelling agent
oral dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/214,412
Inventor
Curtis Wright
Benjamin Oshlack
Christopher Breder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Purdue Pharma LP
Original Assignee
Euro Celtique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to US31053401P priority Critical
Application filed by Euro Celtique SA filed Critical Euro Celtique SA
Priority to US10/214,412 priority patent/US20030068375A1/en
Assigned to EURO-CELTIQUE S.A. reassignment EURO-CELTIQUE S.A. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BREDER, CHRISTOPHER, WRIGHT, CURTIS, OSHLACK, BENJAMIN
Publication of US20030068375A1 publication Critical patent/US20030068375A1/en
Priority claimed from US11/525,395 external-priority patent/US7727557B2/en
Assigned to PURDUE PHARMA L.P. reassignment PURDUE PHARMA L.P. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: EURO-CELTIQUE S.A.
Assigned to PURDUE PHARMACEUTICALS L.P., THE P.F. LABORATORIES, INC., PURDUE PHARMA L.P. reassignment PURDUE PHARMACEUTICALS L.P. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: PURDUE PHARMA L.P.
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29218415&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20030068375(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US14/470,662 external-priority patent/US20150031718A1/en
Assigned to PURDUE PHARMA L.P. reassignment PURDUE PHARMA L.P. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: PURDUE PHARMA TECHNOLOGIES, INC., THE P.F. LABORATORIES, INC.
Abandoned legal-status Critical Current

Links